Cargando…

Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19

Bronchoalveolar lavage has a specific place in the diagnosis of COVID-19. The clinical performance of BAL rRt-PCR is dynamic in nature and depends on different clinical and demographic factors. https://bit.ly/3aZUAPB

Detalles Bibliográficos
Autores principales:	Aggarwal, Deepak, Saini, Varinder
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453730/ https://www.ncbi.nlm.nih.gov/pubmed/32859675 http://dx.doi.org/10.1183/13993003.03116-2020

Ejemplares similares

Factors limiting the utility of bronchoalveolar lavage in the diagnosis of COVID-19
por: Salton, Francesco, et al.
Publicado: (2020)

Limited role for bronchoalveolar lavage to exclude COVID-19 after negative upper respiratory tract swabs: a multicentre study
por: Geri, Pietro, et al.
Publicado: (2020)

Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis
por: Darlington, Pernilla, et al.
Publicado: (2020)

The (in)significance of TB and COVID-19 co-infection
por: Khurana, Alkesh Kumar, et al.
Publicado: (2020)

Does bronchoscopy help the diagnosis in COVID-19 infection?
por: Ora, Josuel, et al.
Publicado: (2020)

Risk factors for viral RNA shedding in COVID-19 patients
por: Fu, Yu, et al.
Publicado: (2020)

Short-term outcomes of COVID-19 and risk factors for progression
por: Long, Li, et al.
Publicado: (2020)

Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support
por: Riera, Jordi, et al.
Publicado: (2022)

COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission
por: Nagra, Deepak, et al.
Publicado: (2020)

High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)
por: Dhooria, Sahajal, et al.
Publicado: (2022)

Diagnostic utility of bronchoalveolar lavage
por: Radha, Sistla, et al.
Publicado: (2014)

COVID-19 phenotypes: leading or misleading?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Response to COVID-19 phenotyping correspondence
por: Bos, Lieuwe D.J., et al.
Publicado: (2020)

Healthcare workers with COVID-19 in Mexico
por: Ñamendys-Silva, Silvio A.
Publicado: (2020)

On tuberculosis and COVID-19 co-infection
por: Tadolini, Marina, et al.
Publicado: (2020)

Current smoking is not associated with COVID-19
por: Rossato, Marco, et al.
Publicado: (2020)

COVID-19 and the nicotinic cholinergic system
por: Farsalinos, Konstantinos, et al.
Publicado: (2020)

Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia
por: Seren, Seda, et al.
Publicado: (2021)

Face masks, respiratory patients and COVID-19
por: Soriano, Joan B., et al.
Publicado: (2020)

Correlation and causality: a COVID-19 conundrum
por: Morice, Alyn H.
Publicado: (2020)

COVID-19 and smoking: is nicotine the hidden link?
por: Russo, Patrizia, et al.
Publicado: (2020)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

Is high-dose glucocorticoid beneficial in COVID-19?
por: Muthu, Valliappan, et al.
Publicado: (2021)

The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
por: Klok, Frederikus A., et al.
Publicado: (2020)

Increased focus on non-animal models for COVID-19 and non-COVID lung research
por: Gribaldo, Laura, et al.
Publicado: (2021)

Smoking, ACE-2 and COVID-19: ongoing controversies
por: Leung, Janice M., et al.
Publicado: (2020)

COVID-19 in Italy: passing through bitter waters
por: Guglielmetti, Lorenzo, et al.
Publicado: (2020)

COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020)

Arterial hypertension and the risk of severity and mortality of COVID-19
por: Leiva Sisnieguez, Carlos Enrique, et al.
Publicado: (2020)

Cardiovascular comorbidity and its impact on patients with COVID-19
por: Guan, Wei-jie, et al.
Publicado: (2020)

Reply: Is high-dose glucocorticoid beneficial in COVID-19?
por: Edalatifard, Maryam, et al.
Publicado: (2021)

Intrapulmonary bronchopulmonary anastomoses in COVID-19 respiratory failure
por: Galambos, Csaba, et al.
Publicado: (2021)

Between inflammation and thrombosis: endothelial cells in COVID-19
por: Birnhuber, Anna, et al.
Publicado: (2021)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Remote monitoring of oxygen saturation in individuals with COVID-19 pneumonia
por: O'Carroll, Orla, et al.
Publicado: (2020)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

To compare the incomparable: COVID-19 pneumonia and high-altitude disease
por: Strapazzon, Giacomo, et al.
Publicado: (2020)

Association between age and clinical characteristics and outcomes of COVID-19
por: Liu, Yang, et al.
Publicado: (2020)

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_csu2smdphos4s1nih6io7l8qv6